Health And Medicine

Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered. Read More

Compounds developed at Vanderbilt University may offer a new way to block influenza infection. Read More

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development. Read More

Vanderbilt University is one of four sites in the United States and Canada to enroll children with autism in a study to examine weight gain commonly experienced while taking antipsychotic medication. Read More

Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the "hunger hormone" ghrelin might indicate who is susceptible to weight regain. Read More

Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory. Read More

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis. Read More

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications. Read More

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders. Read More

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered. Read More

Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease. Read More

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence. Read More

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers. Read More

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies. Read More

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders. Read More

Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation. Read More

Vanderbilt University researchers have received a five-year, $1.2 million grant from the Fogarty International Center of the National Institutes of Health (NIH) to strengthen research ethics capacity in Mozambique. Read More

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Read More

The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics. Read More

The fungicide amphotericin B may be a useful treatment for a frog fungus that is killing amphibians worldwide. Read More